I am really excited about the development planning for AstraZeneca/MedImmune’s world class research facility in the Cambridge BioMedical Campus.
I congratulate the Swiss architecture firm of Herzog & de Meuron who are leading the design of the research and development facility and corporate headquarters for the pharmaceutical giant in Cambridge, UK.
Keys to its design are:
Science which is quite literally the heart of the building program. The triangular shaped building was chosen to reduce journey times when moving around the building and encourage more staff interaction. The building will feature the latest in high-technology laboratories and a central courtyard and serrated glass to promote collaboration through ‘visible science’ and help ensure scientific innovation stays the primary focus for the whole organization.
The importance of Cross Collaboration greatly influenced the site selection and building design, which includes a number of open spaces and connecting thoroughfares to encourage the informal collaboration not only within AstraZeneca and MedImmune, but also with the wider scientific community.
The building shape, scale and design acknowledges Cambridge’s history and the unique characteristics the of Cambridge’s historic centre, which consists of low-rise buildings with central courtyards that are open to the public.
Finally and perhaps most importantly, a new level of Sustainability has been incorporated into the proposed structure. It’s critically important that new buildings make sense for the long-term, with green roofs, transport plans, water management, the low energy design of laboratories and the ground source heat pump all being important elements of the plans.
The design of the site reflects the company’s aim to create an open, welcoming and vibrant headquarters and research center.